Lionco Pharmaceutical Group Co.,Ltd. (SHA:603669)
4.630
+0.070 (1.54%)
Feb 4, 2026, 3:00 PM CST
-14.89% (1Y)
| Market Cap | 3.26B -7.2% |
| Revenue (ttm) | 430.61M +55.3% |
| Net Income | -118.38M |
| EPS | -0.16 |
| Shares Out | 703.54M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 6,899,500 |
| Average Volume | 9,326,403 |
| Open | 4.570 |
| Previous Close | 4.560 |
| Day's Range | 4.550 - 4.640 |
| 52-Week Range | 3.450 - 7.050 |
| Beta | 0.34 |
| RSI | 44.01 |
| Earnings Date | Apr 25, 2026 |